Literature DB >> 23738499

Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy.

Gaetano Zaccara1, Sanjay M Sisodiya, Fabio Giovannelli, Matthew C Walker, Dominic C Heaney, Heather Angus-Leppan, Tim Wehner, Sofia H Eriksson, Rebecca Liu, Fergus Rugg-Gunn, Simon D Shorvon, Josemir W Sander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23738499      PMCID： PMC3853543          DOI： 10.1111/bcp.12175

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs.

Authors:  M C Walker; J W Sander
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

2.  Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions.

Authors:  Daniel Friedman; Jacqueline A French
Journal:  Lancet Neurol       Date:  2012-09       Impact factor: 44.182

3.  Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.

Authors:  S D Shorvon; A Löwenthal; D Janz; E Bielen; P Loiseau
Journal:  Epilepsia       Date:  2000-09       Impact factor: 5.864

4.  Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.

Authors:  P Boon; P Chauvel; B Pohlmann-Eden; C Otoul; S Wroe
Journal:  Epilepsy Res       Date:  2002-01       Impact factor: 3.045

5.  Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.

Authors: 
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

6.  Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.

Authors:  M J Brodie; J P Mumford
Journal:  Epilepsy Res       Date:  1999-04       Impact factor: 3.045

7.  Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.

Authors:  Steve Chung; Michael R Sperling; Victor Biton; Gregory Krauss; David Hebert; G David Rudd; Pamela Doty
Journal:  Epilepsia       Date:  2010-01-27       Impact factor: 5.864

8.  Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures.

Authors:  J Boas; M Dam; M L Friis; O Kristensen; B Pedersen; J Gallagher
Journal:  Acta Neurol Scand       Date:  1996-10       Impact factor: 3.209

9.  Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. The M88-194 Study Group.

Authors:  L J Willmore; V Shu; B Wallin
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

10.  Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.

Authors:  G J Schapel; R G Beran; F J Vajda; S F Berkovic; M L Mashford; F M Dunagan; W C Yuen; G Davies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154
View more
  3 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.

Authors:  Gaetano Zaccara; Fabio Giovannelli; Gail S Bell; Josemir W Sander
Journal:  Eur J Clin Pharmacol       Date:  2014-03-28       Impact factor: 2.953

Review 3.  Tolerability of new antiepileptic drugs: a network meta-analysis.

Authors:  Gaetano Zaccara; Fabio Giovannelli; Filippo Sean Giorgi; Valentina Franco; Sara Gasparini; Umberto Benedetto
Journal:  Eur J Clin Pharmacol       Date:  2017-04-04       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.